Impact of Vendor Systems on Ambulatory Medication Safety
NCT ID: NCT00773500
Last Updated: 2012-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2008-09-30
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Electronic Prescribing and Electronic Transmission of Discharge Medication Lists
NCT00603070
Improving Safety By Computerizing Outpatient Prescribing
NCT00235027
Outpatient Prescription Errors: Detection, Analysis, and Impact on Safety
NCT00256568
An Intuitive, Non-intrusive, Approach to Reduce Patient Harm From Inappropriate Dosing of High-risk Drugs in Older Adult Patients Across an Urban Safety Net Hospital System
NCT05218343
Multi-Center Medication Reconciliation Quality Improvement Study
NCT01337063
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Providers adopting electronic prescribing in New York City, New York
Electronic prescribing
Implementation of a commercially available electronic prescribing system with clinical decision support
2
Providers adopting electronic prescribing in the Taconic region of New York
Electronic prescribing
Implementation of a commercially available electronic prescribing system with clinical decision support
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Electronic prescribing
Implementation of a commercially available electronic prescribing system with clinical decision support
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Agency for Healthcare Research and Quality (AHRQ)
FED
Weill Medical College of Cornell University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rainu Kaushal, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Weill Medical College of Cornell University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Taconic IPA
Fishkill, New York, United States
New York City Department of Health and Mental Hygiene
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Abramson EL, Pfoh ER, Barron Y, Quaresimo J, Kaushal R. The effects of electronic prescribing by community-based providers on ambulatory medication safety. Jt Comm J Qual Patient Saf. 2013 Dec;39(12):545-52. doi: 10.1016/s1553-7250(13)39070-9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U18HS0169705E
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.